A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations.

Saved in:

Bibliographic Details
Title:	A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations.
Authors:	Roche, Michael^1,2, Salimi, Hamid^1,3, Duncan, Renee¹, Wilkinson, Brendan L.⁴, Chikere, Kelechi⁵, Moore, Miranda S.^1,6, Webb, Nicholas E.⁵, Zappi, Helena^1,7, Sterjovski, Jasminka¹, Flynn, Jacqueline K.^1,2, Ellett, Anne¹, Gray, Lachlan R.^1,8, Lee, Benhur⁵, Jubb, Becky⁹, Westby, Mike⁹, Ramsland, Paul A.^10,11,12, Lewin, Sharon R.^1,2,13, Payne, Richard J.⁴, Churchill, Melissa J.^1,3,14, Gorry, Paul R.^1,2,7 gorry@burnet.edu.au
Source:	Retrovirology. 2013, Vol. 10 Issue 1, p1-20. 20p. 2 Diagrams, 3 Charts, 8 Graphs.
Database:	Academic Search Ultimate

Description
ISSN:	17424690
DOI:	10.1186/1742-4690-10-43